Nichola Eliovits

Nichola Eliovits is an accomplished professional with extensive experience in leadership roles across various companies. Currently serving as a Board Observer at Fuze Health and a Board Member at Maverick Metals and Phoenix Tailings, Nichola has also held key positions as Managing Partner at Olive Tree Capital and Chief Financial Officer & Co-Founder at DermBiont, Inc. since 2017. Nichola's previous experience includes Board Memberships at Alto Pharmacy and Downstream.ai, with the latter being acquired by NYSE: SNAP. Additionally, Nichola has contributed insights as a Board Observer for Kaleido Biosciences, a company listed on NASDAQ: KLDO. Educational credentials include a degree from the Questrom School of Business at Boston University.